Triamcinolone and Advair diskus 100/50 drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Triamcinolone and Advair diskus 100/50. Common interactions include non-hodgkin's lymphoma among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people who take Triamcinolone and Advair diskus 100/50 have. It is created by eHealthMe based on reports of 95 people who take Triamcinolone and Advair diskus 100/50 from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Nov, 27, 2022

95 people who take Triamcinolone and Advair diskus 100/50 together, and have interactions are studied.


What is Triamcinolone?

Triamcinolone has active ingredients of triamcinolone. eHealthMe is studying from 18,190 Triamcinolone users for its effectiveness, alternative drugs and more.

What is Advair diskus 100/50?

Advair diskus 100/50 has active ingredients of fluticasone propionate; salmeterol xinafoate. It is often used in asthma. eHealthMe is studying from 39,244 Advair diskus 100/50 users for its effectiveness, alternative drugs and more.

Number of Triamcinolone and Advair diskus 100/50 reports submitted per year:

Triamcinolone and Advair diskus 100/50 drug interactions.

Common Triamcinolone and Advair Diskus 100/50 drug interactions by gender *:

female:

  1. Non-hodgkin's lymphoma
  2. Oedema peripheral
  3. Pain in jaw
  4. Pneumonia staphylococcal
  5. Sebaceous gland disorder
  6. Sinusitis
  7. Spinal cord compression
  8. Spinal osteoarthritis
  9. Swelling
  10. Weight decreased

male:

  1. Dyspnoea
  2. Osteoarthritis
  3. Pneumonia
  4. Blood creatinine increased
  5. Bronchitis
  6. Decreased activity
  7. Hypertension
  8. Pain in extremity
  9. Pleural effusion
  10. Cardiac failure congestive

Common Triamcinolone and Advair Diskus 100/50 drug interactions by age *:

0-1:

n/a

2-9:

  1. Bronchitis
  2. Oesophageal pain

10-19:

  1. Abdominal pain
  2. Biliary dyskinesia
  3. Cholelithiasis
  4. Gastritis
  5. Hiatus hernia
  6. Nausea
  7. Weight decreased
  8. Gastritis erosive
  9. Hypophagia

20-29:

  1. Abdominal pain
  2. Cholelithiasis
  3. Gallbladder disorder
  4. Gastrointestinal injury
  5. Anaemia
  6. Biliary dyskinesia
  7. Blood alkaline phosphatase increased
  8. Cerebral haemorrhage
  9. Cholesterosis
  10. Cough

30-39:

  1. Schizophrenia
  2. Deep vein thrombosis
  3. Dermatitis allergic
  4. Dyspnoea
  5. Exercise tolerance decreased
  6. Fear
  7. Heart rate irregular
  8. Pain
  9. Perivascular dermatitis
  10. Pulmonary embolism

40-49:

  1. Alopecia
  2. Arthralgia
  3. Bronchitis
  4. Cellulitis
  5. Chest pain
  6. Depression
  7. Dysphagia
  8. General physical health deterioration
  9. Influenza
  10. Intervertebral disc protrusion

50-59:

  1. Impaired healing
  2. Actinomycosis
  3. Alveolar osteitis
  4. Arthralgia
  5. Back pain
  6. Balance disorder
  7. Blood creatinine increased
  8. Bone disorder
  9. Breath odour
  10. Cardiac arrest

60+:

  1. Dyspnoea
  2. Nausea
  3. General physical health deterioration
  4. Hypertension
  5. Hypokalaemia
  6. Oedema peripheral
  7. Pneumonia
  8. Pruritus
  9. Anaemia
  10. Dyspepsia

Common conditions people have *:

  1. Pain: 19 people, 20.00%
  2. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 14 people, 14.74%
  3. Metastases To Bone (cancer spreads to bone): 9 people, 9.47%
  4. Depression: 8 people, 8.42%
  5. Abdominal Pain: 8 people, 8.42%
  6. Insomnia (sleeplessness): 7 people, 7.37%
  7. Stress And Anxiety: 6 people, 6.32%
  8. Metastases To Central Nervous System (cancer spreads to central nervous system): 5 people, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Triamcinolone and Advair diskus 100/50?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Common Triamcinolone and Advair diskus 100/50 interactions:

Browse all drug interactions of Triamcinolone and Advair diskus 100/50:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Triamcinolone interactions:

Browse all interactions between Triamcinolone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Advair diskus 100/50 interactions:

Browse all interactions between Advair diskus 100/50 and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on triamcinolone and fluticasone propionate; salmeterol xinafoate (the active ingredients of Triamcinolone and Advair diskus 100/50, respectively), and Triamcinolone and Advair diskus 100/50 (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Triamcinolone and Advair diskus 100/50.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: